You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 30 January 2025

Sec. Microbial Immunology

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1557327

Corrigendum: Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients

  • 1. Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa

  • 2. Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, United States

  • 3. Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States

  • 4. Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil

  • 5. Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil

  • 6. Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa

  • 7. Global Division, The Aurum Institute, Johannesburg, South Africa

  • 8. Department of Infection and Immunity, University College of London, London, United Kingdom

  • 9. Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States

  • 10. Centers for AIDS Research and Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, United States

Article metrics

View details

1,2k

Views

386

Downloads

In the published article, there was an error in the article title. Instead of “Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment”, it should be “Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

tuberculosis, bioenergetic metabolism, lymphocytes, monocytes, TB treatment, cytokines, Seahorse XF96

Citation

Cumming BM, Addicott KW, Maruri F, Pillay V, Asmal R, Moodley S, Barreto-Durate B, Araújo-Pereira M, Mazibuko M, Mhlane Z, Mbatha N, Khan K, Makhari S, Karim F, Peetluk L, Pym AS, Moosa MYS, van der Heijden YF, Sterling TS, Andrade BB, Leslie A and Steyn AJC (2025) Corrigendum: Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients. Front. Immunol. 16:1557327. doi: 10.3389/fimmu.2025.1557327

Received

08 January 2025

Accepted

09 January 2025

Published

30 January 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Adrie J. C. Steyn, ;

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics